Ablation of the thyroid remnant and I-131 dose in differentiated thyroid cancer: a meta-analysis revisited (Q36868332)

16 August 2017

1 reference

title

Ablation of the thyroid remnant and I-131 dose in differentiated thyroid cancer: a meta-analysis revisited (English)

1 reference

differentiated thyroid carcinoma

16 August 2017

1 reference

Suhail A R Doi

1

1 reference

16 August 2017

Nicholas J Woodhouse

series ordinal

2

1 reference

16 August 2017

Lukman Thalib

series ordinal

3

1 reference

16 August 2017

Adedayo Onitilo

series ordinal

4

1 reference

16 August 2017

1 June 2007

1 reference

Clinical Medicine & Research

16 August 2017

1 reference

16 August 2017

5

1 reference

16 August 2017

2

1 reference

16 August 2017

87-90

1 reference

131I activity for remnant ablation in patients with differentiated thyroid cancer: A systematic review

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905932

Follow-up of differentiated thyroid carcinoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905932

Efficacy of I131 ablation therapy using different doses as determined by postoperative thyroid scan uptake in patients with differentiated thyroid cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905932

Radioiodine ablation of residual tissue in thyroid cancer: relationship between administered activity, neck uptake and outcome

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905932

Evaluation of low-dose radioiodine ablation therapy in postsurgical thyroid cancer patients.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905932

Papillary and follicular thyroid cancer: impact of treatment in 1578 patients

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905932

Low dose radioiodide thyroid ablation in postsurgical patients with thyroid cancer

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905932

Radioiodine-131 in differentiated thyroid cancer: a retrospective analysis of an uptake-related ablation strategy

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905932

The effects of radioactive iodine in thyroid remnant ablation and treatment of well differentiated thyroid carcinoma

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905932

Natural history, treatment, and course of papillary thyroid carcinoma

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905932

Radioiodine-131 therapy for well-differentiated thyroid cancer--a quantitative radiation dosimetric approach: outcome and validation in 85 patients

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1905932

Ablation of the thyroid remnant and 131I dose in differentiated thyroid cancer

4 September 2018

1 reference

12 December 2020

[Early evaluation of treatment effectiveness using 131I iodine radiotherapy in patients with differentiated thyroid cancer]

1 reference

12 December 2020

Radioiodine dose for remnant ablation in differentiated thyroid carcinoma: a randomized clinical trial in 509 patients

1 reference

12 December 2020

Comparison of 30- and 50-mCi doses of iodine-131 for thyroid ablation

1 reference

12 December 2020

Ablation of nonmalignant thyroid remnants with low doses of radioactive iodine: concise communication

1 reference

12 December 2020

High or low dose radioiodine ablation of thyroid remnants?

1 reference

12 December 2020

[Comparison of 30mCi and higher doses of iodine-131 for postoperative thyroid remnant ablation]

1 reference

12 December 2020

Ablative radioactive iodine therapy for apparently localized thyroid carcinoma. A decision analytic perspective

1 reference

12 December 2020

Comparison of 1073 MBq and 3700 MBq iodine-131 in postoperative ablation of residual thyroid tissue in patients with differentiated thyroid cancer

1 reference

12 December 2020

Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer

1 reference

12 December 2020

Prospective randomized clinical trial to evaluate the optimal dose of 131 I for remnant ablation in patients with differentiated thyroid carcinoma

1 reference

12 December 2020

Use of radioactive iodine for thyroid remnant ablation in well-differentiated thyroid carcinoma to replace thyroid reoperation

1 reference

12 December 2020

Prescribing 131Iodine based on neck uptake produces effective thyroid ablation and reduced hospital stay

1 reference

12 December 2020

Efficacy of low and high 131I doses for thyroid remnant ablation in patients with differentiated thyroid carcinoma based on post-operative cervical uptake

1 reference

12 December 2020

Prognostic significance of successful ablation with radioiodine of differentiated thyroid cancer patients

1 reference

12 December 2020

Identifiers

DOI

10.3121/CMR.2007.763

1 reference

16 August 2017

1 reference

16 August 2017

PubMed publication ID

17607042

1 reference